Stockscreener 앱 받기
13.73
1.43%
-0.2166
전일 마감가:
$13.95
열려 있는:
$13.79
하루 거래량:
29,771
Relative Volume:
0.09
시가총액:
$182.03M
수익:
$1.93M
순이익/손실:
$-7.96M
주가수익비율:
-0.00389
EPS:
-3530.8178
순현금흐름:
$-36.78M
1주 성능:
-1.79%
1개월 성능:
+29.05%
6개월 성능:
+180.61%
1년 성능:
+44.13%
1일 변동 폭
$13.70
$14.48
1주일 범위
$13.40
$15.99
52주 변동 폭
$3.39
$16.00
아발로 테라퓨틱스 Stock (AVTX) Company Profile
명칭
Avalo Therapeutics Inc
전화
410-522-8707
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
AVTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
13.84 | 248.31M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.74 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.18 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.12 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 재확인 | H.C. Wainwright | Buy |
| 2025-09-05 | 개시 | TD Cowen | Buy |
| 2025-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Jefferies | Buy |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-28 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | Wedbush | Outperform |
| 2024-12-19 | 개시 | BTIG Research | Buy |
| 2024-10-24 | 개시 | H.C. Wainwright | Neutral |
| 2024-04-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 개시 | RBC Capital Mkts | Outperform |
모두보기
아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스
Technical analysis overview for Avalo Therapeutics Inc. stockQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
Real time social sentiment graph for Avalo Therapeutics Inc.Portfolio Risk Report & Real-Time Volume Spike Alerts - newser.com
Avalo Therapeutics Inc. stock trend forecastMarket Movement Recap & Consistent Profit Trade Alerts - newser.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
How high can Avalo Therapeutics Inc. stock goJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView
Should I buy Avalo Therapeutics Inc. (C6K0) stock before earnings season2025 Year in Review & Fast Entry and Exit Trade Plans - newser.com
How Avalo Therapeutics Inc. stock performs in weak economyRecession Risk & Smart Swing Trading Techniques - newser.com
Can Avalo Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Will Avalo Therapeutics Inc. see short term momentumWall Street Watch & Low Risk Growth Stock Ideas - newser.com
Will Avalo Therapeutics Inc. stock benefit from upcoming earnings reportsWeekly Trade Analysis & Capital Efficiency Focused Ideas - newser.com
Is Avalo Therapeutics Inc. (C6K0) stock positioned for secular growthRate Hike & Breakout Confirmation Alerts - newser.com
How moving averages guide Avalo Therapeutics Inc. trading2025 Biggest Moves & AI Driven Stock Reports - newser.com
Can Avalo Therapeutics Inc. (C6K0) stock sustain revenue momentum2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Is Avalo Therapeutics Inc a good long term investmentRisk Mitigation Techniques & Free Superior Profit Margins - earlytimes.in
How Avalo Therapeutics Inc. (C6K0) stock responds to job market shiftsNew Guidance & Smart Investment Allocation Insights - newser.com
Why Avalo Therapeutics Inc. (C6K0) stock remains top rated2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Significant Increase in Short Interest - Defense World
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - MarketBeat
Avalo Therapeutics Strengthens Leadership with Key Appointments - The Globe and Mail
Avalo Therapeutics Expands Leadership Team with Key - GlobeNewswire
Avalo Therapeutics, Inc. Announces Board Appointments, Effective October 1, 2025 - MarketScreener
Avalo Therapeutics expands leadership with two senior appointments By Investing.com - Investing.com Canada
Avalo Therapeutics expands leadership with two senior appointments - Investing.com India
Former Longboard $2.6B Deal Architect Joins Avalo Therapeutics as CBO Ahead of Key Trial Results - Stock Titan
BTIG Research Reiterates “Buy” Rating for Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Avalo Therapeutics' (AVTX) Buy Rating Reiterated at BTIG Research - MarketBeat
BTIG Reiterates Avalo Therapeutics (AVTX) Buy Recommendation - Nasdaq
BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
What drives Avalo Therapeutics Inc stock priceSector Performance Drivers & Free Dashboard to Track Market Momentum - earlytimes.in
What analysts say about Avalo Therapeutics Inc stockBlue Chip Stock Analysis & Superior Trading Ideas - earlytimes.in
Where Analysts See GVP Infotech Limited Stock by Year EndGap Up/Gap Down Analysis & Minimal Investment Portfolio Growth - earlytimes.in
What high frequency data says about Avalo Therapeutics Inc.Weekly Market Report & Weekly High Momentum Picks - newser.com
아발로 테라퓨틱스 (AVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아발로 테라퓨틱스 주식 (AVTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Almenoff June Sherie | Director |
Nov 12 '24 |
Buy |
12.50 |
500 |
6,250 |
500 |
0.21%
2.95%
자본화:
|
볼륨(24시간):